Clinical Trials in Birmingham - 24 Recruiting Industry Studies

Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim · started 2025-09-13

📍 Antrim · Bath · Birmingham · Leeds · London

NCT06806592 on ClinicalTrials.gov ↗

Recruiting Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Boehringer Ingelheim · started 2025-07-22

📍 Birmingham · Blackburn · Bournemouth · Bradford · Bristol

NCT07064473 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Heart Failure
Novo Nordisk A/S · started 2025-06-27

📍 Birmingham · High Wycombe · London · Middlesbrough · Southampton

NCT06979362 on ClinicalTrials.gov ↗

Recruiting Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim · started 2025-06-09

📍 Belfast · Birmingham · Blackpool · Bradford · Bristol

NCT06872892 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

Chronic Kidney Disease
Boehringer Ingelheim · started 2025-12-09

📍 Birmingham · Bristol · Glasgow · Liverpool · London

NCT07107945 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics · started 2025-01-28

📍 Aberdeen · Birmingham · Cambridge · Glasgow · Leeds

NCT06788990 on ClinicalTrials.gov ↗

Active Phase 3

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer · started 2014-12-17

📍 Glasgow · Wonford · London · Sutton · Birmingham

NCT02319837 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc. · started 2020-12-02

📍 Birmingham · Edinburgh · Kent · Leicester · London

NCT04613596 on ClinicalTrials.gov ↗

Recruiting Phase 2

Rescue of Nephrons With ALE.F02 (RENAL-F02)

Glomerulonephritis Rapidly Progressive
Alentis Therapeutics AG · started 2023-09-07

📍 Birmingham · Cambridge · Liverpool · London · Manchester

NCT06047171 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

CLL, Chronic Lymphocytic Leukemia
BeOne Medicines · started 2025-04-10

📍 Aberdeen · Birmingham · Bournemouth · London · Southampton

NCT06846671 on ClinicalTrials.gov ↗

Recruiting Phase 3

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Multiple Myeloma
Pfizer · started 2024-02-08

📍 Milton Keynes · Bodelwyddan · Bournemouth · Poole · Eastbourne

NCT06152575 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Boehringer Ingelheim · started 2024-05-06

📍 Aberdeen · Birmingham · Bristol · Edinburgh · Exeter

NCT06238622 on ClinicalTrials.gov ↗

Recruiting

Registry for Patients With X-Linked Hypophosphatemia

X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd · started 2017-09-12

📍 Belfast · Birmingham · Bristol · Cambridge · Cardiff

NCT03193476 on ClinicalTrials.gov ↗

Active Phase 3

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Follicular Lymphoma (FL)
Genmab · started 2022-09-20

📍 Plymouth · Glasgow · London · Oxford · Leeds

NCT05409066 on ClinicalTrials.gov ↗

By invitation Phase 3

An Open-label Study of XEN1101 in Epilepsy

Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc. · started 2023-04-25

📍 Leeds · Cardiff · Birmingham · London · Oxford

NCT05718817 on ClinicalTrials.gov ↗

Active Phase 3

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

NASH, Cirrhosis, Liver
Madrigal Pharmaceuticals, Inc. · started 2022-08-26

📍 Birmingham · Cambridge · London

NCT05500222 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis
Regeneron Pharmaceuticals · started 2021-12-14

📍 Sheffield · Birmingham

NCT05070858 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 118 Manchester · 30 Glasgow · 27 Cambridge · 27 Birmingham · 24 Leicester · 23 Bristol · 23 Leeds · 22 Sutton · 19 Oxford · 19 Liverpool · 18 Edinburgh · 15 Nottingham · 14 Cardiff · 14 Newcastle upon Tyne · 13 Sheffield · 12

Browse by condition

Obesity · 5 Chronic Lymphocytic Leukemia · 5 Cancer · 4 Breast Neoplasms · 3 Non-small Cell Lung Cancer · 3 Small Lymphocytic Lymphoma · 3 Multiple Myeloma · 3 Hypertension · 3 Heart Failure · 3 Triple Negative Breast Neoplasms · 2 Lymphoma, Non-Hodgkin · 2 Lymphoma, Follicular · 2 Lymphoma, Large B-Cell, Diffuse · 2 Gastric Cancer · 2 Metastatic Prostate Cancer · 2 Overweight · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/birmingham (Accessed: 11 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.